Colistimethate Sodium Dry Powder for Inhalation: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Colistimethate Sodium Dry Powder for Inhalation: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
Authors
Keywords
Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Tobramycin, Colistin, Polymyxin
Journal
DRUGS
Volume 74, Issue 3, Pages 377-387
Publisher
Springer Nature
Online
2014-02-07
DOI
10.1007/s40265-014-0181-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model
- (2014) P Tappenden et al. HEALTH TECHNOLOGY ASSESSMENT
- Targeting protein-protein interactions to rescue Δf508-cftr: a novel corrector approach to treat cystic fibrosis
- (2013) Isabel Devesa et al. EMBO Molecular Medicine
- Pharmacology of polymyxins: new insights into an ‘old’ class of antibiotics
- (2013) Tony Velkov et al. Future Microbiology
- Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
- (2012) Ami F. Mohamed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoPharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection
- (2012) Wang Hengzhuang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
- (2012) Phillip J. Bergen et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin against Pseudomonas aeruginosa
- (2012) C Bozkurt-Guzel et al. Indian Journal of Medical Microbiology
- Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis
- (2012) Clement L. Ren et al. Journal of Cystic Fibrosis
- Comparison of adherence between twice- and thrice-daily regimens of oral amoxicillin/clavulanic acid
- (2012) CARL LLOR et al. RESPIROLOGY
- Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
- (2012) Antje Schuster et al. THORAX
- Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem on Mucoid and Nonmucoid Pseudomonas aeruginosa Biofilms
- (2011) Wang Hengzhuang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis
- (2011) Niels Høiby BMC Medicine
- Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)
- (2011) A. C. Gales et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients
- (2011) Argyris S Michalopoulos et al. Annals of Intensive Care
- Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model
- (2010) P. J. Bergen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
- (2010) Roberto Imberti et al. CHEST
- fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
- (2010) R. V. Dudhani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
- (2010) Michael W. Konstan et al. Journal of Cystic Fibrosis
- Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
- (2010) Lauren M Lim et al. PHARMACOTHERAPY
- Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models
- (2009) R. V. Dudhani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
- (2009) Joshua D. Hartzell et al. CLINICAL INFECTIOUS DISEASES
- Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus
- (2009) Harry Heijerman et al. Journal of Cystic Fibrosis
- Aerosol Antibiotics in Cystic Fibrosis
- (2009) David E Geller Respiratory Care
- In vitro Activities of Various Antibiotics, Alone and in Combination with Colistin Methanesulfonate, against Pseudomonas aeruginosa Strains Isolated from Cystic Fibrosis Patients
- (2008) Çağla Bozkurt Güzel et al. CHEMOTHERAPY
- Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
- (2008) P. J. Bergen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The prevalence of cystic fibrosis in the European Union
- (2008) Philip M. Farrell Journal of Cystic Fibrosis
- High treatment burden in adults with cystic fibrosis: Challenges to disease self-management
- (2008) Gregory S. Sawicki et al. Journal of Cystic Fibrosis
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started